This continues to appear on the Brainchip website under the “see what they are saying”banner regarding the release of AKIDA 2.0 section:
“We see an increasing demand for real-time, on-device, intelligence in AI applications powered by our MCUs and the need to make sensors smarter for industrial and IoT devices. We licensed Akida neural processors because of their unique neuromorphic approach to bring hyper-efficient acceleration for today’s mainstream AI models at the edge. With the addition of advanced temporal convolution and vision transformers, we can see how low-power MCUs can revolutionize vision, perception, and predictive applications in a wide variety of markets like industrial and consumer IoT and personalized healthcare, just to name a few.- Roger Wendelken, Senior Vice President at Renesas’ IoT and Infrastructure Business Unit”
Before this statement in December, 2022 Renesas announced they were taping out an AKIDA based MCU and this appeared as a story in the EETimes magazine. This EE Times story is still promoted on Brainchip’s website and was verified at the time on BRAINCHIP’s LinkedIn.
Renesas operates a just in time model which means it does not warehouse chips but rather produces them when ordered. It is reasonable to assume in the absence of orders/sales Renesas would not produce the AKIDA MCU.
I personally would expect that the demand experience and long adoption cycles described by Brainchip in attempting to sell AKIDA technology would be mirrored across the industry and also be experienced by Renesas, Megachip, Socionext, MOSCHIP and others.
My opinion only DYOR
Fact Finder
- Forums
- ASX - By Stock
- BRN
- 2025 BrainChip Discussion
BRN
brainchip holdings ltd
Add to My Watchlist
2.56%
!
19.0¢

2025 BrainChip Discussion, page-3889
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
19.0¢ |
Change
-0.005(2.56%) |
Mkt cap ! $384.8M |
Open | High | Low | Value | Volume |
19.5¢ | 20.0¢ | 19.0¢ | $831.1K | 4.310M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
30 | 619632 | 19.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
19.5¢ | 597469 | 20 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
29 | 567001 | 0.190 |
44 | 2160537 | 0.185 |
67 | 1515373 | 0.180 |
24 | 529738 | 0.175 |
47 | 1008434 | 0.170 |
Price($) | Vol. | No. |
---|---|---|
0.195 | 597469 | 20 |
0.200 | 570209 | 26 |
0.205 | 565640 | 16 |
0.210 | 3126417 | 28 |
0.215 | 1049250 | 20 |
Last trade - 16.18pm 25/06/2025 (20 minute delay) ? |
Featured News
BRN (ASX) Chart |
The Watchlist
PTX
PRESCIENT THERAPEUTICS LIMITED
James McDonnell, CEO
James McDonnell
CEO
SPONSORED BY The Market Online